Nephro-Urology Monthly

Published by: Kowsar

Postchemotherapy Retroperitoneal Lymph Node Dissection in Patients With Nonseminomatous Testicular Cancer: A Single Center Experiences

Mohamadreza Nowroozi 1 , Mohsen Ayati 1 , Amir Arbab 1 , Hassan Jamshidian 1 , Hamidreza Ghorbani 2 , Hassan Niroomand 1 , Mohsen Taheri Mahmoodi 1 , Erfan Amini 1 , Sohrab Salehi 2 , Hamid Hakima 2 , Farid Fazeli 1 , Saeid Haghdani 3 and Alireza Ghadian 4 , *
Authors Information
1 Uro-Oncology Research Center, Tehran University of Medical Sciences, Tehran, IR Iran
2 Department of Urology, Qazvin University of Medical Sciences, Qazvin, IR Iran
3 Department of Urology, Shahid Hasheminejad Hospital, Iran University of Medical Sciences, Tehran, IR Iran
4 Nephrology and Urology Research Center, Baqiyatallah University of Medical Sciences, Tehran, IR Iran
Article information
  • Nephro-Urology Monthly: September 01, 2015, 7 (5); e27343
  • Published Online: September 16, 2015
  • Article Type: Research Article
  • Received: January 25, 2015
  • Accepted: February 1, 2015
  • DOI: 10.5812/numonthly.27343

To Cite: Nowroozi M, Ayati M, Arbab A, Jamshidian H, Ghorbani H, et al. Postchemotherapy Retroperitoneal Lymph Node Dissection in Patients With Nonseminomatous Testicular Cancer: A Single Center Experiences, Nephro-Urol Mon. 2015 ; 7(5):e27343. doi: 10.5812/numonthly.27343.

Copyright © 2015, Nephrology and Urology Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Akbari ME, Hosseini SJ, Rezaee A, Hosseini MM, Rezaee I, Sheikhvatan M. Incidence of genitourinary cancers in the Islamic Republic of Iran: a survey in 2005. Asian Pac J Cancer Prev. 2008; 9(4): 549-52[PubMed]
  • 2. Heidenreich A, Pfister D, Witthuhn R, Thuer D, Albers P. Postchemotherapy retroperitoneal lymph node dissection in advanced testicular cancer: radical or modified template resection. Eur Urol. 2009; 55(1): 217-24[DOI][PubMed]
  • 3. Mosharafa AA, Foster RS, Koch MO, Bihrle R, Donohue JP. Complications of post-chemotherapy retroperitoneal lymph node dissection for testis cancer. J Urol. 2004; 171(5): 1839-41[DOI][PubMed]
  • 4. Stephenson AJ, Tal R, Sheinfeld J. Adjunctive nephrectomy at post-chemotherapy retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer. J Urol. 2006; 176(5): 1996-9[DOI][PubMed]
  • 5. Nash PA, Leibovitch I, Foster RS, Bihrle R, Rowland RG, Donohue JP. En bloc nephrectomy in patients undergoing post-chemotherapy retroperitoneal lymph node dissection for nonseminomatous testis cancer: indications, implications and outcomes. J Urol. 1998; 159(3): 707-10[PubMed]
  • 6. Djaladat H, Nichols C, Daneshmand S. Adjuvant surgery in testicular cancer patients undergoing postchemotherapy retroperitoneal lymph node dissection. Ann Surg Oncol. 2012; 19(7): 2388-93[DOI][PubMed]
  • 7. Rabbani F, Goldenberg SL, Gleave ME, Paterson RF, Murray N, Sullivan LD. Retroperitoneal lymphadenectomy for post-chemotherapy residual masses: is a modified dissection and resection of residual masses sufficient? Br J Urol. 1998; 81(2): 295-300[PubMed]
  • 8. Carver BS, Shayegan B, Eggener S, Stasi J, Motzer RJ, Bosl GJ, et al. Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissection. J Clin Oncol. 2007; 25(28): 4365-9[DOI][PubMed]
  • 9. Ozen H, Ekici S, Sozen S, Ergen A, Tekgul S, Kendi S. Resection of residual masses alone: an alternative in surgical therapy of metastatic testicular germ cell tumors after chemotherapy. Urology. 2001; 57(2): 323-7[PubMed]
  • 10. Nguyen CT, Stephenson AJ. Role of postchemotherapy retroperitoneal lymph node dissection in advanced germ cell tumors. Hematol Oncol Clin North Am. 2011; 25(3): 593-604[DOI][PubMed]
  • 11. Heidenreich A, Thuer D, Polyakov S. Postchemotherapy retroperitoneal lymph node dissection in advanced germ cell tumours of the testis. Eur Urol. 2008; 53(2): 260-72[DOI][PubMed]
  • 12. Aprikian AG, Herr HW, Bajorin DF, Bosl GJ. Resection of postchemotherapy residual masses and limited retroperitoneal lymphadenectomy in patients with metastatic testicular nonseminomatous germ cell tumors. Cancer. 1994; 74(4): 1329-34[PubMed]
  • 13. Oldenburg J, Alfsen GC, Lien HH, Aass N, Waehre H, Fossa SD. Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses. J Clin Oncol. 2003; 21(17): 3310-7[DOI][PubMed]
  • 14. Albers P, Weissbach L, Krege S, Kliesch S, Hartmann M, Heidenreich A, et al. Prediction of necrosis after chemotherapy of advanced germ cell tumors: results of a prospective multicenter trial of the German Testicular Cancer Study Group. J Urol. 2004; 171(5): 1835-8[DOI][PubMed]
  • 15. Comisarow RH, Grabstald H. Re-exploration for retroperitoneal lymph node metastases from testis tumors. J Urol. 1976; 115(5): 569-71[PubMed]
  • 16. Eggener SE, Carver BS, Loeb S, Kondagunta GV, Bosl GJ, Sheinfeld J. Pathologic findings and clinical outcome of patients undergoing retroperitoneal lymph node dissection after multiple chemotherapy regimens for metastatic testicular germ cell tumors. Cancer. 2007; 109(3): 528-35[DOI][PubMed]
  • 17. Steyerberg EW, Keizer HJ, Sleijfer DT, Fossa SD, Bajorin DF, Gerl A, et al. Retroperitoneal metastases in testicular cancer: role of CT measurements of residual masses in decision making for resection after chemotherapy. Radiology. 2000; 215(2): 437-44[DOI][PubMed]
  • 18. Toner GC, Panicek DM, Heelan RT, Geller NL, Lin SY, Bajorin D, et al. Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection. J Clin Oncol. 1990; 8(10): 1683-94[PubMed]
  • 19. Carver BS, Sheinfeld J. Postchemotherapy surgery for germ cell tumors of the testis. Curr Opin Oncol. 2011; 23(3): 271-4[DOI][PubMed]
  • 20. Miki T, Mizutani Y, Nakamura T, Kawauchi A, Nagahara A, Nonomura N, et al. Post-chemotherapy nerve-sparing retroperitoneal lymph node dissection for advanced germ cell tumor. Int J Urol. 2009; 16(4): 379-82[DOI][PubMed]
  • 21. Pettus JA, Carver BS, Masterson T, Stasi J, Sheinfeld J. Preservation of ejaculation in patients undergoing nerve-sparing postchemotherapy retroperitoneal lymph node dissection for metastatic testicular cancer. Urology. 2009; 73(2): 328-31[DOI][PubMed]
  • 22. Spitz A, Wilson TG, Kawachi MH, Ahlering TE, Skinner DG. Vena caval resection for bulky metastatic germ cell tumors: an 18-year experience. J Urol. 1997; 158(5): 1813-8[PubMed]
  • 23. Ahlering TE, Skinner DG. Vena caval resection in bulky metastatic germ cell tumors. J Urol. 1989; 142(6): 1497-9[PubMed]
  • 24. Sonneveld DJ, Sleijfer DT, Koops HS, Keemers-Gels ME, Molenaar WM, Hoekstra HJ. Mature teratoma identified after postchemotherapy surgery in patients with disseminated nonseminomatous testicular germ cell tumors: a plea for an aggressive surgical approach. Cancer. 1998; 82(7): 1343-51[PubMed]
  • 25. Stenning SP, Parkinson MC, Fisher C, Mead GM, Cook PA, Fossa SD, et al. Postchemotherapy residual masses in germ cell tumor patients: content, clinical features, and prognosis. Medical Research Council Testicular Tumour Working Party. Cancer. 1998; 83(7): 1409-19[PubMed]
  • 26. Fizazi K, Tjulandin S, Salvioni R, Germa-Lluch JR, Bouzy J, Ragan D, et al. Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy--results from an international study group. J Clin Oncol. 2001; 19(10): 2647-57[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments